Overexpression of Bcl-X(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model

American Journal of Pathology

Volumn 155, Issue 6, 1999, Pages 1861-1867

  Liu, Rebecca ^a   Page, Carmen ^a   Beidler, David R ^a   Wicha, Max S ^a   Núñez, Gabriel ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; PROTEIN BCL X;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CLONOGENIC ASSAY; CONTROLLED STUDY; GENE OVEREXPRESSION; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032763060     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65505-8     Document Type: Article

References (38)

1. Endicott JA, Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 1989, 58:137-171
2. Ling V: Multidrug resistance molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 1997, 40:3-8
3. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG: Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994, 54:357-361
4. Futscher BW, Abbaszadegan MR, Domann F, Dalton WS Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells. Biochem Pharmacol 1994, 47:1601-1606
5. Zaman GJR, Versantvoort CHM, Smit JJM, Eijdems EWHM, deHaas M, Smith AJ, Broxterman HJ, Mulder NH, de Vries EGE, Baas F, Borst P: Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 1993, 53:1747-1750
6. Barry MA, Behnke CA, Eastman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins, and hyperthermia. Biochem Pharmacol 1990, 40 2343-2362
7. Kaufmann SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 1989, 49:5870-5878
8. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993, 81:151
9. L can confer a multidrug resistance phenotype. Blood 1995, 86 1903
10. L can differentially block chemotherapy-induced cell death. Blood 1997, 90:1208-1216
11. Yang E, Korsmeyer SJ: Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood 1996, 88:386-401
12. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nuñez G: Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 1993, 143:1543-1550
13. Weller M, Malipiero U, Aguzzi A, Reed JC, Fontana A: Protoorcogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest 1995, 95:2633-2643
14. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S, Reed JC: Immunohistochemical analysis of bcl-2, bax, bcl-x, and mcl-1 expression in prostate cancers. Am J Pathol 1996, 148:1567-1576
15. Tu Y, Renner S, Xu F, Fleishman A, Taylor J, Weisz J, Vescio R, Rettig M, Berenson J, Krajewsk S, Reed JC, Lichtenstein A: Bcl-x expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res 1998, 58:256-262
16. Adams JM, Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326
17. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ, Kaufmann SH: Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 1997, 90:935-943
18. Sun X-M, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 1999, 274:5053-5060
19. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud JP, Guyotat D: High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 1993, 81:3091
20. Maung ZT, MacLean FR, Reid MM, Pearson AD, Proctor SJ, Hamilton PJ, Hall AG: The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia. Br J Haematol 1994, 88: 105-109
21. Hill ME, MacLennan KA, Cunningham DC, Vaughan Hudson E, Burke M, Clarke P, Di Stefano F, Anderson L, Vaughan Hudson G, Mason D, Selby P, Linch DC: Prognostic significance of Bcl-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study. Blood 1996, 88:1046-1051
22. Hermine O, Haioun C, Lepage E, d'Agay MF, Briere J, Lavignac C, Fillet G, Salles G, Marolleau JP, Diebold J, Reyas F, Gaulard P: Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood 1996, 87:265-272
23. Lock RB, Stribiniskiene L: Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res 1996, 56:4006-4012
24. Yin DX, Schimke RT: Bcl-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res 1995, 55:4922-4928
25. Kyprianou N, King ED, Bradbury D, Rhee JG: Bcl-2 overexpression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int J Cancer 1997, 70: 341-346
26. Lin JC, Song SW: Influence of vascular thermotolerance on the heat-induced changes in blood flow, pO2, and cell survival in tumors. Cancer Res 1993, 53:2076-2080
27. González-Garcia M, Ballestero R, Ding L, Duan L, Boise L, Duan L, Boise LH, Thompson CB, Nuñez G: Bcl-xL is the major Bcl-x in RNA from expressed during murine development, and its product localizes to mitochondria. Development 1994, 120:3033-3042.
28. L and CD40: dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J Immunol 1995, 155:3830-3838
29. Nishimura R, Nagao K Miyayama H, Matsuda M, Baba K, Matsuoka Y, Yamashita H, Fukuda M, Higu Chi A: Apoptosis in breast cancer and its relationship to clinic pathological characteristics and prognosis. J Surg Oncol 1999, 71:226-234
30. Olopade OI, Adeyanju MO, Safa AR, Hagos F, Mick R, Thompson CB, Recant WM: Overexpression of Bcl-x prote n in primary breast cancer is associated with high tumor grade and nodial metastases. Cancer J Sci Am 1997, 3:230-237
31. L by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth Differ 1995, 6:363-370
32. el Alaoui S, Lawry J, Griffin M: The cell cycle and induction of apoptosis in a hamster fibrosarcoma cell line treated with anti-cancer drugs: its importance to solid tumour chemotherapy. J Neurooncol 1997 31:195-207
33. Walker A, Taylor ST, Hickman JA, Dive C: Germinal center-cerived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells. Cancer Res 1997, 57:1939-1945
34. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nuñez G: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997, 278:687-689
35. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241
36. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J: Inhibition of death receptor signals by cellular FLIP. Nature 1997, 388:190-195
37. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997, 3:917-921
38. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95). Bax, caspases, and anticancer drugs. Cancer Res 1998, 58:5315-5320